Fluorescence studies suggest a role for α-synuclein in the phosphatidylinositol lipid signaling pathway

Biochemistry

Volumn 44, Issue 2, 2005, Pages 462-470

  Narayanan, Vijaya ^a,b   Guo, Yuanjian ^a   Scarlata, Suzanne ^a  

^a STONY BROOK UNIVERSITY   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATION ANALYSIS; BINDING ENERGY; CALCIUM; CATALYSIS; DISEASES; ENZYMES; GENES; PHOSPHATES; PROTEINS; SIGNAL PROCESSING;

Α-SYNUCLEIN; DOPAMINE SIGNALING; MEMBRANE ASSOCIATION; PARKINSON'S DISEASE;

FLUORESCENCE;

ALPHA SYNUCLEIN; CALCIUM; DOPAMINE; GUANINE NUCLEOTIDE BINDING PROTEIN; PHOSPHATIDYLINOSITOL; PHOSPHOLIPASE;

ARTICLE; ARTIFICIAL MEMBRANE; CALCIUM TRANSPORT; CELL CULTURE; DEGENERATIVE DISEASE; FLUORESCENCE ANALYSIS; GENETIC TRANSFECTION; HYDROLYSIS; MEASUREMENT; MUTANT; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION; REGULATORY MECHANISM;

ALPHA-SYNUCLEIN; ANIMALS; CALCIUM; CALCIUM SIGNALING; CELL LINE; DOPAMINE; GTP-BINDING PROTEIN BETA SUBUNITS; GTP-BINDING PROTEIN GAMMA SUBUNITS; HUMANS; INOSITOL PHOSPHATES; ISOENZYMES; LIPID BILAYERS; MICROSCOPY, CONFOCAL; MICROSCOPY, FLUORESCENCE; NERVE TISSUE PROTEINS; PHOSPHATIDYLINOSITOL 4,5-DIPHOSPHATE; PHOSPHATIDYLINOSITOLS; PHOSPHOLIPASE C; PROTEIN BINDING; RATS; SPECTROMETRY, FLUORESCENCE; SYNUCLEINS; UP-REGULATION;

EID: 12144267004     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi0487140     Document Type: Article

References (57)

1. Dawson, T., Mandir, A., and Lee, M. (2002) Animal models of PD: Pieces of the same puzzle? Neuron 35, 219-222.
2. Duda, J. E., Lee, V. M., and Trojanowski, J. Q. (2000) Neuropathology of synuclein aggregates, J. Neurosci. Res. 61, 121-127.
3. Ueda, K., Fukushinma, F., Masliah, E., et al. (1993) Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 90, 11282-11286.
4. Hashimoto, M., Hsu, L. J., Sisk, A., Xia, Y., Takeda, A., et al. (1998) Human recombinant NACP/α-synuclein is aggregated and fibrillated in vitro: Relevance for Lewy body disease, Brain Res. 799, 301-306.
5. Clayton, D. F., and George, J. M. (1998) The synucleins: A family of proteins involved in synaptic function, plasticity, neurodegeneration and disease, Trends Neurosci. 21, 249-254.
6. Lavedan, C. (1998) The synuclein family, Genome Res. 8, 871-880.
7. Clayton, D. F., and George, J. M. (1999) Synucleins in synaptic plasticity and neurodegenerative disorders, J. Neurosci Res. 58, 120-129.
8. Burke, R. E. (1999) α-Synuclein and Parkinson's disease, Brain Res. Bull. 50, 465-466.
9. Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S., Dehejia, A., et al. (1997) Mutation in the α-synuclein gene identified in families with Parkinson's disease, Science 276, 2045-2047.
10. Kruger, R., Muller, T., and Riess, O. (2000) Involvement of α-synuclein in Parkinson's disease and other neurodegenerative disorders, J. Neural Transm. 107, 31-40.
11. Lee, F. J., et al. (2001) Direct binding and functional coupling of α-synuclein to the dopamine transporters accelerate dopamine-induced apoptosis, FASEB J. 15, 916-926.
12. Lotharius, J., and Brundin, P. (2002) Impaired dopamine storage resulting from α-synuclein mutation may contribute to the pathogensis of Parkinson's disease, Hum. Mol. Genet. 11, 2395-2407.
13. George, J. M. (2002) The synucleins, Genome Biol. 3, 3002.1-3002.6.
14. Ostrerova, N., Petrucelli, L., Farrer, M., Mehta, N., Choi, P., et al. (1999) α-Synuclein shares physical and functional homology with 14-3-3 proteins, J. Neurosci. 19, 5782-5791.
15. Jenco, J. M., Rawlingson, A., Daniels, B., and Morris, A. J. (1998) Regulation of phospholipase D2: Selective inhibition of mammalian phospholipase D isoenzymes by α- and β-synucleins, Biochemistry 37, 4901-4909.
16. Weinreb, P. H., Zhen, W., Poon, A. W., Conway, K. A., and Lansbury, P. T., Jr. (1996) NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded, Biochemistry 35, 13709-13715.
17. Conway, K. A., Lee, S. J., Rochet, J. C., Ding, T. T., Williamson, R. E., and Lansbury, P. T., Jr. (2000) Acceleration of oligomerization, not fibrillization, is a shared property of both α-synuclein mutations linked to early-onset Parkinson's disease: Implications for pathogenesis and therapy, Proc. Natl. Acad. Sci. U.S.A. 97, 571-576.
18. Davidson, W. S., Jonas, A., Clayton, D. F., and George, J. M. (1998) Stabilization of α-synuclein secondary structure upon binding to synthetic membranes, J. Biol. Chem. 273, 9443-9449.
19. Lee, H. J., Choi, C., and Lee, S. J. (2002) Membrane-bound α-synuclein has a high aggregation propensity and the ability to seed the aggregation of the cytosolic form, J. Biol. Chem. 277, 671-678.
20. Narayanan, V., and Scarlata, S. (2001) Membrane binding and self-association of α-synuclein, Biochemistry 40, 9927-9934.
21. McLean, P. J., Kawamata, H., Ribich, S., and Hyman, B. T. (2000) Membrane association and protein conformation of α-synuclein in intact neurons. Effect of Parkinson's disease-linked mutations, J. Biol. Chem. 275, 8812-8816.
22. Rebecchi, M. J., and Pentyala, S. N. (2000) Structure, function, and control of phosphoinositide-specific phospholipase C, Physiol. Rev. 80, 1291-1335.
23. Rhee, S. G. (2001) Regulation of phosphoinositide-specific phospholipase C, Annu. Rev. Biochem. 70, 281-312.
24. Rasolonjanahary, R., Gerard, C. M. N. D., Homburger, V., Enjalbert, A., and Guillon, G. (2002) Evidence for a direct negative coupling between dopamine-D2 receptors and PLC by heterotrimeric Gi1/2 in rat anterior pituitary cell membranes, Endocrinology 143, 747-754.
25. Stefanis, L., Kholodilov, N., Rideout, H. G., Burke, R. E., and Greene, L. A. (2001) Synuclein-1 is selectively up-regulated in response to nerve growth factor treatment in PC12 cells, J. Neurochem. 76, 1165-1176.
26. Abeliovich, A., Schmitz, Y., Farinas, I., Choi-Lundberg, D., Ho, W. H., et al. (2000) Mice lacking α-synuclein display functional deficits in the nigrostriatal dopamine system, Neuron 25, 239-252.
27. LaFerla, F. (2002) Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease, Nat. Rev. Neurosci. 3, 862-872.
28. 2+-dependent α-granule release from human platelets, Blood 100, 2506-2514.
29. Runnels, L., and Scarlata, S. (1999) Determination of the affinities between heterotrimeric G protein subunits and their phospholipase C-β effectors, Biochemistry 38, 1488-1496.
30. Wang, T., Pentyala, S., Rebecchi, M. J., and Scarlata, S. (1999) Differential association of the pleckstrin homology domains of phospholipases C-β1, C-β2, and C-δ1 with lipid bilayers and the βγ subunits of heterotrimeric G proteins. Biochemistry 38, 1517-1524.
31. Weernink, P. A., Guo, Y., Zhang, C., Schmidt, M., Von Eichel-Streiber, C., and Jakobs, K. H. (2000) Control of cellular phosphatidylinositol 4,5-bisphosphate levels by adhesion signals and rho GTPases in NIH 3T3 fibroblasts involvement of both phosphatidylinositol-4-phosphate 5-kinase and phospholipase C, Eur. J. Biochem. 267, 5237-5246.
32. 2+ binding α-synuclein regulates ligand binding and oligomerization, J. Biol. Chem. 276, 22680-22684.
33. 2 links the binding of Gβγ to activation of the catalytic core, J. Biol. Chem. 275, 7466-7469.
34. Boyer, J. L., Graber, S. G., Waldo, G. L., Harden, T. K., and Garrison, J. C. (1994) Selective Activation of Phospholipase C by Recombinant G-protein α- and βγ-Subunits, J. Biol. Chem. 269, 2814-2819.
35. Scarlata, S., Ed. (2002) Determination of the strength and specificity of membrane-bound protein association using fluorescence spectroscopy: Application to the G protein-phospholipase C system, Vol. 345. Academic Press, New York.
36. Wach, L., Brink, C., and Norel, X. (2001) The muscarinic receptor subtypes in human blood vessels, Therapie 3, 223-226.
37. Di Salvo, J., and Nelson, S. R. (1998) Stimulation of G-protein coupled receptors in vascular smooth muscle cells induces tyrosine kinase dependent increases in calcium without tyrosine phosphorylation of phospholipase C γ-1, FEBS Lett. 422, 85-88.
38. Hashimoto, M., et al. (1997) NACP, a synaptic protein involved in Alzheimer's disease, is differentially regulated during megakaryocyte differentiation, Biochem. Biophys. Res. Commun. 237, 611-616.
39. Zhou, W., Hurlbert, M. S., Schaack, J., Prasad, K. N., and Freed, C. R. (2000) Overexpression of human α-synuclein causes dopamine neuron death in rat primary culture and immortalized mesencephalon-derived cells, Brain Res. 866, 33-43.
40. Takenouchi, T., et al. (2001) Reduced neuritic outgrowth and cell adhesion in neuronal cells transfected with human α-synuclein, Mol. Cell. Neurosci. 17, 141-150.
41. Takahashi, A. (1999) Measurement of intracellular calcium. Physiol. Rev. 49, 189.
42. Kobayashi, S., Ikeda, K., Miyata, K., Yamada, T., and Honda, K. (2001) A method for measurement of muscarinic receptor-mediated responses in dissociated single colon longitudinal smooth muscle cells, J. Phamacol. Toxicol. Methods 45, 199-205.
43. Berridge, M. J., Lipp, P., and Bootman, M. D. (2000) The versatility and universality of calcium signaling, Nat. Rev. Mol. Cell Biol. 1, 11-21.
44. 2+ mobilization in smooth muscle cell, Biochem. Biophys. Res. Commun. 160, 758-764.
45. Maroteaux, L., and Scheller, R. H. (1991) The rat brain synucleins: Family of proteins transiently associated with neuronal membrane, Brain Res. Mol. Brain Res. 11, 335-343.
46. Marui, W., Iseki, E., Ueda, K., and Kosaka, K. (2000) Occurrence of human α-synuclein immunoreactive neurons with neurofibrillary tangle formation in the limbic areas of patients with Alzheimer's disease, J. Neurol. Sci. 174, 81-84.
47. Mizuguchi, M., Yamada, M., Kim, S. U., and Rhee, S. G. (1991) Phospholipase C isozymes in neurons and glial cells in culture: An immunocytochemical and immunochemical study, Brain Res. 548, 35-40.
48. Gerfen, C. R., Choi, W. C., Suh, P. G., and Rhee, S. G. (1988) Phospholipase C I and II brain isozymes: Immunohistochemical localization in neuronal systems in rat brain, Proc. Natl. Acad. Sci. U.S.A. 55, 3208-3212.
49. Ishibashi, T., Yoshida, Y., Imai, S., and Nishio, M. (1999) IP3 production in A10 cells, an established aortic smooth muscle cultured cell line: Effects of agonist administration procedure and culture conditions, Gen. Pharmacol. 32, 115-121.
50. Lopez, I., Mak, E. C., Ding, J., Hamm, H. E., and Lomasney, J. W. (2001) A novel bifunctional phospholipase C that is regulated by Gα 12 and stimulates the Ras/mitogen-activated protein kinase pathway, J. Biol. Chem. 276, 2758-2765.
51. Wing, M., Houstaon, D., Kelley, G., Der, C., Siderovski, D., and Harden, K. (2001) Activation of phospholipase C-ε by heterotrimeric G protein βγ subunits, J. Biol. Chem. 276, 48257-48251.
52. Kelley, G. G., Reks, S. E., and Smrcka, A. V. (2004) Hormonal regulation of phospholipase Cε through distinct and overlapping pathways involving G12 and Ras family G-proteins, Biochem. J. 378, 129-139.
53. Maroteaux, L., Campanelli, J. T., and Scheller, R. H. (1988) Synuclein: A neuron-specific protein localized to the nucleus and presynaptic nerve terminal, J. Neurosci. 8, 2804-2815.
54. Martinez, J., Moeller, I., Erdjument-Bromage, H., Tempst, P., and Lauring, B. (2003) Parkinson's disease-associated α-synuclein is a calmodulin substrate, J. Biol. Chem. 278, 17379-17387.
55. Jensen, P. H., Islam, K., Kenney, J., Nielsen, M. S., Power, J., and Gai, W. P. (2000) Microtubule-associated protein 1B is a component of cortical Lewy bodies and binds α-synuclein filaments, J. Biol. Chem. 275, 21500-21507.
56. Iwata, A., Miura, S., Kanazawa, I., Sawada, M., and Nukina, N. (2001) α-Synuclein forms a complex with transcription factor Elk-1 1, J. Neurochem. 77, 239-252.
57. Jo, E., McLaurin, J., Yip, C. M., St George-Hyslop, P., and Fraser, P. E. (2000) α-Synuclein membrane interactions and lipid specificity, J. Biol. Chem. 275, 34328-34334.